RT30 (30mg)
$220.00
RT30 is an investigational once-weekly injectable drug designed to treat obesity and related metabolic conditions. For lab research only.
Description
Dosage (Male)
1–12 mg once weekly (titrated)
Dosage (Female)
1–12 mg once weekly (titrated)
Frequency
Once per week
Dosage Type
Subcutaneous Injection
Active Half-Life
6–7 days
Post-Cycle PCT
N/A
Reviews
There are no reviews yet.